United Kingdom · Who invested in Alchemab Therapeutics?
Alchemab Therapeutics's investors include DCVC, RA Capital Management, Eli Lilly, British Business Bank and SV Health Investors.
202120222023202420252026
$27MSeries A$24MSeries A$34MSeries AUnited Kingdom · Series A startup
Who invested in Alchemab Therapeutics
3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 4 months ago
Funding summaryUpdated 26 Oct 2026
$85Mraised across 3 rounds since 2021, from 3 sources
$27MSeries A$24MSeries A$34MSeries A
- Latest round
- Series A, $34MJul 2026
- Step-upi
- 1.4×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $27M Apr 2021
- Biggest round
- $34M Series A · Jul 2026
- Usual gap between rounds
- 3.3 years the median of 2
The rounds
- Jul 2026Series A$34M5 new
Source recorded
- Feb 2023Series A$24M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Apr 2021Series A$27M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2021Series A2023Series A2026
DCVC
RA Capital Management
Eli Lilly
British Business BankSV Health Investors
DCVCRA Capital ManagementEli LillyBritish Business BankSV Health InvestorsEveryone who backed them
SV Health InvestorsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Alchemab Therapeutics
How much has Alchemab Therapeutics raised?
Alchemab Therapeutics has raised $85M across 3 rounds since 2021.
When did Alchemab Therapeutics last raise?
Alchemab Therapeutics's most recent round was a Series A of $34M in Jul 2026.
What was Alchemab Therapeutics's biggest round?
Its most recent round, $34M in Jul 2026, is also its largest on record.
Who backed Alchemab Therapeutics first?
Alchemab Therapeutics's first round on record, in Jul 2026, was backed by DCVC, RA Capital Management and Eli Lilly and 2 others.
What stage is Alchemab Therapeutics at?
Alchemab Therapeutics's latest named round is a Series A, in Jul 2026.
Where is Alchemab Therapeutics based?
Alchemab Therapeutics is based in the United Kingdom.
Companies like Alchemab Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.